Catherine Sanders

Catherine Sanders

Company: Adaptive Biotechnologies

Job title: VP Research Sales & Business Development


Using Adaptive’s Immune Medicine Platform to Advance Cell Therapies in Oncology 9:30 am

Adaptive’s Immune Medicine Platform leverages proprietary chemistry, computational biology, and machine learning to read and understand patient’s immune systems. Adaptive has developed a best-in-class, high-throughput T cell receptor (TCR) screening platform that allows the discovery of naturally-occurring, potent, ultra-low frequency TCRs with differentiated therapeutic potential. The Adaptive TruTCR discovery engine has allowed the selection and…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.